Defined Raw Materials – Robust Biomanufacturing

Read our article in International Biopharmaceutical Industry (IBI), Autumn 2026: A recombinant and animal-origin-free raw material strategy for antibody, vaccine and cell & gene therapy manufacturing.

Read the article on Issuu